OpenAI has unveiled GPT‑Rosalind, a large language model tuned specifically for biology. The new system aims to curb the over‑enthusiasm and sycophancy that have plagued earlier models, offering more skeptical, fact‑checked responses on drug targets and other scientific queries. Access is restricted to U.S. entities through a trusted‑deployment program, with a broader Life Sciences Research Plugin slated for later release. OpenAI cites safety concerns, including the risk of the model being used to optimize harmful viruses, as the reason for the limited rollout. Read more →